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In the Tromsø study, we have successfully used high resolution ultrasonography for assessing athero-
sclerosis development in a general population. The method is well suited for large epidemiological surveys. 
Methodological problems could be overcome by using highly standardized protocols, pre-study training of 
sonographers and readers, and off-line computer-based batch reading of digitized images. The Tromsø 
study has added new and important knowledge in the field of carotid atherosclerosis regarding prevalence, 






Atherosclerotic plaques are the underlying cause of the 
majority of myocardial infarction (MI) and ischemic 
strokes. The ability to both identify persons with athe-
rosclerosis and quantify the extent of atherosclerosis is 
of great value in stratifying the future risk for cardio-
vascular diseases and also for monitoring ongoing 
treatment. High-resolution B-mode ultrasonography of 
the carotid arteries provides measures of intima-media 
thickness (IMT) and atherosclerotic plaques, both 
widely used as surrogate measures of cardiovascular 
disease. It is a cheap, mobile, and easily available 
method and has practically no complications or side 
effects. The ultrasound images show excellent accor-
dance with the true arterial wall structures and wall 
thickness in histological studies (1), is highly corre-
lated with known vascular risk factors (2,3) and with 
risk scores (4-6). The finding of carotid atherosclerosis 
correlates well with the extent of atherosclerotic dis-
ease elsewhere (7-9), and can predict future vascular 
events, like MI and stroke (3,10-12). The validity of B-
mode ultrasound imaging to detect asymptomatic 
carotid artery atherosclerosis combined with high 
measurement reproducibility provides a powerful non-
invasive scientific tool to test cross-sectional and pros-
pective hypotheses related to disease epidemiology. 
Carotid ultrasound is used in several large population-
based studies around the world (i.e ARIC, CHS, 
Rotterdam). Ultrasound examination of the carotid 
artery was implemented in the Tromsø Study as a part 
of the fourth survey in 1994-95. 
 IMT is made up of approximately 80% media 
(smooth muscle cells) and 20% intima (endothelial 
layer, basal lamina and subendothelial matrix). High 
resolution ultrasound can not differentiate between the 
two layers (Figure 1). Increased IMT can therefore be 
due to both medial hypertrophy and widening of the 
subintimal space. However, atherosclerosis is largely 
an intimal process with deposition of cholesterol and 
cell infiltration. Intima-media thickening, especially in 
its early development, reflects a hypertensive hyper-
trophic response of the medial cells related to changes 
in local shear stress and tensile stress, and is likely to 
reflect the influence of genes related to hypertension, 
such as angiotensin II, and angiotensin converting 
enzyme (13,14). In contrast, formed arterial plaques 
probably represent a later stage of atherogenesis rela-
ted to inflammation, oxidation, endothelial dysfunc-
tion, and/or smooth muscle cell proliferation (15). The 
pathological processes leading to intima-media thicke-
ning and to plaque formation may therefore not be 
similar, and plaque and intima-media thickening may 
reflect different biological aspects of atherogenesis 
with distinctive relations to clinical vascular disease. 
IMT has usually been measured in the distal part of the 
common carotid artery (CCA) because high measure-
ment precision is more easily obtained from this seg-
ment of the artery. However, plaques are rare in this 
arterial segment. Plaques usually occur at sites of non-
laminar turbulent flow, such as in the carotid bulb and 
the proximal internal carotid segment (ICA) (16,17). 
 Whereas IMT is solely a quantitative measure that 
is measured continuously, carotid plaques can be 
assessed both quantitatively as a categorical variable 
(present/absent) and continuously (plaque numbers, 
plaque thickness, plaque area, plaque volume) and 
qualitatively, reflecting the composition of the plaque 
or plaque content (plaque echogenicity, plaque hetero-
geneity, plaque texture, measured either in categories 
or continuously) (Figure 2). Plaques that appear 
echolucent (low echogenicity) have a thin fibrous cap 
overlaying a lipid core with numerous macrophages, 
and are recognized as inflammatory plaques (18). The 
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Figure 1.  Marked interfaces of a characteristic longitudinal ultrasound image of the distal common carotid artery. In the near 
wall, the distance between the trailing edge of the periadventitia-adventitia interface (1) and the trailing edge of the intima-
lumen interface (3) represents the intima-media thickness (IMT). In the far wall, the distance between the leading edge of the 
lumen-intima interface (4) and the leading edge of the media-adventitita interface (4) represents the IMT. The distance 









presence of echolucent plaques is associated with 
higher risk of coronary and cerebrovascular ischemic 
events than echogenic plaques (18-20). 
 IMT measurements provide information on cardio-
vascular risk even when no plaque is present. This can 
be an advantage in population based studies where a 
significant proportion of the participants have no 
plaques. On the other hand, IMT is a relatively insensi-
tive measure of plaque evolution since plaque grows 
longitudinally along the carotid axis of flow more than 
2 times faster than it thickens (21). Because the annual 
rate of progression of IMT is below the resolution of 
carotid ultrasound (~0.3mm), large sample sizes are 
required to evaluate changes. Each dimension added 
(from one-dimensional IMT to 2D plaque area, and to 
3D plaque volume) substantially lowers the sample 
size and duration of studies required to evaluate pro-
gression (22). Plaque area and volume measurements 
may therefore be more sensitive and representative 
measures of the atherosclerotic burden than plaque 
thickness or IMT. Total carotid plaque area is also a 
stronger predictor of events than IMT (12,23). How-
ever, IMT is often used as endpoint in efficacy studies 
and consensus on how to standardize measurements 
exists (24), whereas there is greater variety in plaque 
definitions across studies. Different investigators have 
proposed different definitions of plaque. Most charac-
terize plaque as a localized protrusion into the vessel 
wall with a diameter that is at least 50% greater than 
the normal appearing nearby IMT segment (25). 
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METHODOLOGICAL CHALLENGES 
 
Precise measurements are mandatory to make a good 
study. There are four important sources of variability 
in quantification of ultrasound assessed atherosclero-
sis: Choice of segments to measure, choice of equip-
ment, sonographer error and reader error. Averages of 
several measurements taken from any single individual 
should provide greater reproducibility than any indi-
vidual measurement (26). This provides the rationale 
for obtaining multiple IMT measurements from each 
segment of the artery (the near and far walls of the 
distal CCA, the bifurcation and the proximal ICA) and 
presenting results as the mean value of repeated con-
secutive measurements. A second source of variability 
is the ultrasound equipment. Many large multicenter 
epidemiologic studies have purchased uniform equip-
ment and provided centralized standardisation across 
clinical sites to avoid this problem. 
 Different sonographers have potential to introduce 
significant variability into ultrasound readings. Ultra-
sound scanning is operator dependent, and the infor-
mation obtained depends on the sonographers experi-
ence and technique. Plaques are small structures that 
easily can be overlooked. This is especially true for 
low-echogenic plaques located in the near wall of the 
artery and plaques located in the ICA, a segment 
which is technically more difficult to visualize. It is 
crucial to use the optimal insonation angle and 
visualize the artery in the diameter where the plaque is 
thickest. When beams of ultrasonic waves hit a struc-
ture (e.g vessel wall, a plaque) perpendicularly, the 
reflection will be optimal. Otherwise, some of the 
waves are scattered and reflected away from the trans-
ducer, and the quality of the B-mode image may be-
come insufficient for analytical purposes, with unsharp 
contours, loss of small structures, and distortion of 
proportions within the image. 
 Variability between readers can also be substantial. 
If the scanning period is long, drift in both measure-
ment and reading may be a problem as well. This can 
be reduced by “batch reading” by one single reader at 
the end of the study, automated image quantification, 
training and retraining of readers as well as sonogra-
phers. Repetitive reproducibility studies at fixed inter-
vals should be implemented to ensure a high-quality 
classification practice during the whole survey period. 
Computer-assisted off-line classification represents a 
more objective method with better reproducibility 
(18,27). 
 Data on measurement agreement (at both inter- and 
intraobserver level) should be available when inter-
preting the results of ultrasound studies. In studies on 
progression, the measurement errors of at least two 
measurements are accumulated, giving substantially 
lower statistical power compared to baseline measure-
ments only. Studies on progression require a higher 
level of reproducibility, more demanding techniques 
and highly standardized protocols that include the 
definition of anatomical landmarks, control of probe 
insonation angle, and careful circumferential scanning 
of segments to identify the maximum wall thickness. 
Random measurement errors will always tend to atte-
nuate the true associations found in a study, whereas 
systematic errors (bias) may influence the association 
in either direction. The measurement errors in carotid 
ultrasonography are still too big to study progression 
of atherosclerosis between two points of time at an 
individual level. At a population level however, the 
large number will give enough power to overcome the 
measurement variability, and make it possible to detect 




ULTRASONOGRAPHY OF THE CAROTID 
ARTERIES IN THE TROMSØ STUDY 
 
Subjects and methods 
 
The Tromsø study is a population-based prospective 
study with repeated health surveys of inhabitants in the 
municipality of Tromsø, Norway. The main focus has 
been on cardiovascular diseases. In 1994 (baseline), all 
subjects aged 55-74 years and a random 5-10% sample 
in the other age groups > 24 years, were invited to 
ultrasound scanning of the carotid artery. In all, 6892 
subjects (79% of the eligible population) attended for 
ultrasound screening. Of these persons, ultrasonogra-
phy of the right carotid artery was performed in 6727 
subjects. In the follow-up survey in 2001, all partici-
pants who were still alive and living in Tromsø were 
invited to a new examination. Ultrasound examination 
of the right carotid artery was performed in 5454 
persons, in whom 4858 were examined for the second 
time. The right carotid artery was scanned longitudi-
nally from the level of the clavicle, through the carotid 
bulb (bifurcation segment) and the ICA as far down-
stream as possible. The same ultrasound equipment 
(Acuson Xp10 128, ART upgraded, with a 7.5-MHz 
linear-array transducer, aperture size 38 mm) with 
standardized and fixed instrument set-up was used in 
both surveys. We used no fixed insonation angle, but 
recorded plaques and IMT at angles that gave techni-
cally best and most adequate view of IMT, plaque size 
and echogenicity. To ensure equal and standardized 
examination techniques and measurement procedures, 
all sonographers completed a 2-month pre-study 
training protocol. 
 A plaque was defined as a localised protrusion of 
the vessel wall into the lumen of at least 50% com-
pared to the adjacent IMT. In each subject, a maxi-
mum of 6 plaques were registered in the near and far 
walls of CCA, bifurcation, and ICA, respectively. 
Plaque echogenicity was scored visually as echolucent, 
predominantly echolucent, predominantly echogenic, 
or echogenic. Digitalized longitudinal plaque images 
were transferred to and standardized in Adobe Photo-
shop, to calculate the plaque area and generate median 
values for the gray-scale pixel distribution of each 
plaque (the gray-scale median, GSM), an objective 
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measure of plaque echogenicity (28). In subjects with 
more than one plaque, the areas of all plaques were 
summarized to give the total plaque area. The GSM of 
the total plaque area was estimated as a weighted mean 
of the GSM value of each single plaque. Carotid 
stenosis was defined by one or both of the following 
criteria: 1) Peak systolic velocity in tightest stenotic 
part ≥ 0.2 m/sec higher than peak systolic velocity in 
the post-stenotic ICA segment, or ≥ 0.1 m/sec if the 
stenosis was located to the bifurcation/bulb. 2) A 
plaque thickness that constituted 35% or more of the 
lumen diameter at the plaque site. Subjects were 
referred to the Department of Neurology, University 
Hospital of North Norway if a suspected carotid steno-
sis or occlusion were found. 
 Automated R-triggered measurement of the right 
carotid IMT was performed in the near and far walls of 
the CCA and the far wall of the bulb (29). Measure-
ments of IMT and CCA-lumen diameter were 
analyzed off-line by a an automated computerized 
edge-detection program developed by the Wallenberg 
Laboratory for Cardiovascular Research, Sahlgrenska 
University Hospital, Gothenburg University, Gothen-
burg, Sweden (30). The computer program estimates 
the mean IMT and lumen diameter from 100 measure-
ments along a predefined 10 mm segment of the CCA 
and the carotid bulb. In the analyses, we used the ave-
rage of the mean IMT of the 3 locations. 
 
Aims of the study  
Since atherosclerosis is an intermediate stage between 
risk factor exposition and clinical manifest cardio-
vascular disease, carotid atherosclerosis can be studied 
by two different approaches. If a measure of athero-
sclerosis (such as IMT, plaque presence, or plaque 
area) is used as surrogate endpoint, we can define this 
as the dependent variable in the statistical analyses and 
study which risk factors that independently predict 
development and progression of atherosclerosis. On 
the other hand, measures of atherosclerosis can be de-
fined as independent variables in the study of athero-
sclerotic burden as predictor for myocardial infarction 
and ischemic stroke. In the Tromsø Study, we have 
used both approaches. Firstly, we estimated the distri-
bution of and risk factors for IMT, and prevalence of 
and risk factors for atherosclerotic plaques and carotid 
stenosis in a general population. Secondly, we charac-
terized risk factors for progression of carotid athero-
sclerosis. Finally, carotid atherosclerosis was evalua-





The intra-and interobserver agreement on plaque 
occurrence and visual assessed plaque echogenicity is 
displayed in Table 1. In the baseline survey in the 
Tromsø study, all plaque classification was performed 
off-line in one batch by one single reader at the end of  
Table 1. Observer agreement (overall agreement in pooled 
analyses) on plaque detection and visual classification of 




Κ (95% CI) 
Intra-observer 
agreement 
Κ (95% CI) 
Baseline (1994/95)   
    Plaque detection 0.72 (0.60–0.84) 0.76 (0.63–0.89) 
    Plaque echogenicity 0.73 (0.59–0.87) 0.69 (0.55–0.83) 
Follow-up (2001)   
    Plaque detection 0.67 (0.58–0.76) 0.80 (0.70–0.91) 




the study (31). This gave a uniform and consistent 
classification. In the follow-up survey, plaque assess-
ment was performed on-line by four different readers 
(28). The rationale for doing this was the assumption 
that on-line reading would give a truer picture of 
plaque echogenicity. In spite of good agreement in the 
reproducibility studies at both baseline and follow-up, 
there were substantial differences in the relative 
distribution of plaque echogenicity classes in the two 
surveys. Subsequent analysis indicated that the classi-
fication practice in the follow-up survey had been 
modified over time, and that this variation would 
undermine a valid comparison between echogenicity in 
the two surveys. Therefore, all plaque images in the 
baseline- and follow-up survey were reclassified in 
one batch by two readers, using computer-assisted ana-
lysis (28). In Table 2, reproducibility data on compu-
terized measures of plaque area and plaque GSM are 
given. Reproducibility of plaque area and GSM mea-
surements was overall good with small inter-observer 
mean arithmetic and mean absolute differences. How-
ever, the limits of agreement indicate that a change in 
plaque area of as much as 8-9 mm2 and a change in 
plaque GSM of as much as 19 can be attributed to 
measurement error when applying carotid ultrasound 
at an individual level. The mean degree of stenosis and 
median absolute difference between observers of the 
estimated degree of stenosis by the velocity method 
were 46.3 and 10.8%, respectively. The corresponding 
values were 51.0 and 5.8% for the diameter method 
and 57.1 and 7.2%, for the cross-sectional lumen 
method. The limits of agreement for intersonographer 
reproducibility varied between ±19.7 and 26.5% (32). 
For IMT, the mean inter- and intraobserver absolute 
differences were 0.21 mm and 0.22 mm respectively 
(29). 
 
Distribution of and risk factors for IMT 
In the baseline survey, IMT and cardiovascular risk 
factors were measured in 6408 men and women aged 
25-84 years (33). The distribution of IMT is shown in 
Figure 3. Age, systolic blood pressure, total choleste-
rol, HDL cholesterol, body mass index, and smoking 
were independent predictors of IMT in both sexes. 
Fibrinogen levels and physical activity were associated 
with IMT in men only, whereas triglyceride levels 
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Inter-observer     
       Plaque GSM 50.9 (28.8) –1.7 (–2.6, –0.7) 5.9 (8.0) ± 19.2 
       Plaque area (mm2) 13.9 (9.0) –1.0 (–1.4, –0.6) 2.9 (3.4) ± 8.6 
     
Intra-observer     
   Observer A     
       Plaque GSM 50.2 (27.6) –0.1 (–1.0, 0.8) 3.8 (4.8) ± 12.0 
       Plaque area (mm2) 13.4 (7.9)   0.2 (–0.2, 0.7) 1.8 (2.5) ± 6.1      
   Observer B     
       Plaque GSM 51.8 (30.2) –0.9 (–2.2, 0.4) 5.3 (7.0) ± 17.1 





Figure 3.  A) Percentile distribution of mean IMT in the far wall of the common carotid artery (top panel), the near wall of 
the common carotid artery (middle panel) and the far wall of the carotid bifurcation (bottom panel) related to age. Men are 
shown in solid lines, women in dashed lines. Percentiles shown are from top to bottom the 95th, 50th and 5th percentile. 
B) Age-adjusted values of mean IMT (± SE) by systolic blood pressure (top panel), total cholesterol (middle panel) and 
HDL-cholesterol (bottom panel). Men are shown in solid lines, women in dashed lines. From Stensland-Bugge E, et al. 




were associated with IMT independently of HDL cho-
lesterol in women only. A family history of cardiovas-
cular disease (CVD) was an independent predictor of 
IMT in both sexes, also when controlling for traditio-
nal CVD risk factors. The magnitude of the association 
between most risk factors and IMT did not differ 
depending on age, but the effects of physical activity 
and triglycerides were more pronounced at higher age. 
These data suggest that there are significant age and 
sex differences in the distribution and the determinants 
of subclinical atherosclerosis. We have also reported 
an inverse association between total testosterone levels 
and IMT in the carotid artery in men that was present 
also after excluding men with cardiovascular disease, 
but was not independent of BMI (34). The clinical 
relevance of this is uncertain and needs to be investi-
gated in a clinical setting. No significant relationship 
between carotid IMT and serum TSH levels was 
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observed in normal, non thyroxine taking, subjects. 
Carotid IMT was increased in subjects taking thyr-
oxine. Whether the increase in IMT is due to thyroxine 
ingestion or underlying thyroid disease cannot be 
answered from the study (35). 
 
Prevalence of carotid plaques and carotid stenosis 
At baseline, the prevalence and echogenicity of carotid 
plaques were registered in 3016 men and 3404 women 
(17). Plaque morphology was graded according to 
echogenicity. Atherosclerotic plaques were found in 
55.4% of the men and 45.8% of the women. In men, 
there was a linear increase in plaque prevalence with 
age, whereas in women, there was a curvilinear age 
trend, with an inflection in the prevalence rate of 
women at approximately 50 years of age (Figure 4A). 
The male predominance in atherosclerosis declined 
after the age of 50 years, the plaque prevalence being 
similar in elderly men and women. Men had more low-
echogenic plaques than women (Figure 4B); this sex 
difference in plaque echogenicity increased signifi-
cantly (P = 0.005) with age. The sex difference in the 
prevalence of plaque and the female age trend in athe-
rosclerosis showed significant changes at the age of 
approximately 50 years, suggesting an adverse effect 
of menopause on atherosclerosis. The higher propor-
tion of soft low-echogenic plaques in men compared 
with women increased with age and may partly 
account for the prevailing male excess risk of coronary 
heart disease in the elderly despite a similar prevalence 
of atherosclerosis in elderly men and women. 
 The prevalence of carotid stenosis was 3.8% (95% 
CI 3.2–4.6%) in men and 2.7% (95% CI 2.2–3.3%) in 
women (P = 0.001) (36). The prevalence gradually in-
creased by age in both genders. Cholesterol, HDL 
cholesterol (inverse), fibrinogen, systolic blood pres-
sure levels and current smoking were independently 
associated with carotid artery stenosis in both women 
and men. The presence of carotid stenosis was signi-
ficantly associated with a history of cerebrovascular 
disease, coronary heart disease and peripheral artery 
disease. Low levels of HDL cholesterol and increasing 
degree of stenosis were independently associated with 
an increased risk of having an echolucent plaque (37). 
 
Predictors of plaque formation 
In a follow-up study, we examined predictors of novel 
plaque development in 2610 persons who had no 
plaque present at the baseline survey in 1994 (38). At 
baseline, we measured all traditional cardiovascular 
risk factors as well as novel risk factors like monocyte 
count, white cell count and fibrinogen. At follow-up, 
the number of novel plaques was grouped as none, 1 
plaque, and 2 or more plaques. In a multivariate ord-
inal logistic regression model, age, sex, total choleste-
rol, current smoking, systolic blood pressure, IMT and 
monocyte count were independent predictors of novel 
plaque formation (Table 3). No significant association 
was found between plaque formation and either white  
 
Figure 4.  A) Prevalence of carotid plaque by age and sex. 
B) Prevalence of echolucent (soft) carotid plaques by age 
and sex. From Joakimsen O, et al. Arterioscler Thromb 




Table 3.  Predictors of novel plaque formation. The Tromsø Study. 
 
Risk factor χ2 OR (95% CI) 
Monocyte count x109/L 14.1 1.18 (1.08–1.29) 
Age, y 58.2 1.61 (1.42–1.81) 
Male sex   9.2 1.33 (1.11–1.59) 
Total cholesterol, mmol/L 25.2 1.26 (1.15–1.38) 
Current smoking 28.4 1.73 (1.41–2.11) 
Systolic blood pressure, mm Hg 23.2 1.25 (1.14–1.37) 
Intima-media thickness, mm 46.8 1.43 (1.29–1.58) 
R2  0.19 
 
The multivariate adjusted odds ratio predicts the probability of 
being in a higher category (more plaques) for 1 SD increase in the 
independent continuous variable or for being a male or current 
smoker. From Johnsen SH, et al. Stroke 2005; 36: 715-719. 
 
 
blood cell count or fibrinogen. This was the first pros-
pective study demonstrating that elevated monocyte 
count in blood is an early marker of future plaque 
development. The findings fit well with the biologic 
model of atherogenesis where activation of monocytes 
and differentiation into lipid-laden macrophages are 
fundamental events in generation of atherosclerotic 
lesions. In the highest monocyte quartile, the risk for 
CAROTID ULTRASONOGRAPHY IN THE TROMSØ STUDY  23 
 
Table 4.  Predictors of plaque area progression. The Tromsø Study. 
 
 Model I  Model II  Model III  Model IV 
Risk factor ß* (SE) P  ß* (SE) P  ß* (SE) P  ß* (SE) P 
HDL cholesterol, mmol/L –0.95 (0.43) 0.02  –0.98 (0.44) 0.03  –0.93 (0.44) 0.03  –1.46 (0.48) 0.002 
Age, year ... ...    1.47 (0.43) 0.0006    1.46 (0.45) 0.001    1.34 (0.48) 0.005 
Male sex ... ...    1.07 (0.89) 0.2    1.13 (0.91) 0.2    1.25 (0.99) 0.2 
Total cholesterol, mmol/L ... ...  ... ...  –0.28 (0.44) 0.5    0.73 (0.51) 0.2 
Systolic blood pressure, mm Hg ... ...  ... ...    1.21 (0.44) 0.006    1.07 (0.48) 0.03 
Smoking, yes vs. no ... ...  ... ...    3.18 (0.92) 0.0005    3.20 (1.00) 0.001 
 
*Values are regression coefficients (SE) expressed in mm2 for a 1-SD change in continuous variables and for presence vs. absence of 
categorical variables. 
Model I was unadjusted. 
Model II was adjusted for age and sex. 
Model III was adjusted for age, sex, total cholesterol, systolic blood pressure, and smoking. 
Model IV excluded persons who had ever used lipid-lowering drugs (n = 442). 




having plaque compared with the lowest quartile was 
1.85 (OR) (95% CI 1.41–2.43). Repeating the analysis 
without IMT did not change the monocyte estimate. 
Excluding subjects with known cardiovascular disease 
and diabetes mellitus from analysis neither changed 
this. Monocytes were not associated with IMT neither 
at baseline nor follow-up in persons who remained 
plaque free, suggesting that differences in monocyte 
activity is a determining factor for plaque formation 
but not for diffuse thickening of the intima-media 
layer. In cross-sectional analysis, women with late 
menopause and women who ever had used postmeno-
pausal estrogens had significantly less plaques than 
women with early menopause and never users of 
estrogen (39). The ApoC-I content of VLDL particles 
was associated with plaque size in persons with carotid 
atherosclerosis (40). Our findings support the concept 
that the number of apoC-I per VLDL-particle may be 
of importance for initiation and progression of 
atherosclerosis. We found no evidence for persistent 
Chlamydia pneumoniae or cytomegalovirus infection 
in subjects with carotid plaque (41). 
 
Risk factors associated with plaque echogenicity 
In subjects with carotid stenosis, low levels of HDL 
cholesterol were independently associated with an 
increased risk of having an echolucent, rupture-prone 
atherosclerotic plaque. For 1-SD increase in HDL 
cholesterol, the risk of having lower plaque echo-
genicity decreased by approximately 30% (OR 0.69, 
95% CI 0.52–0.93) (37). Subjects with echolucent 
plaques had delayed postprandial clearance of chylo-
micron triglycerides compared to controls. Low lipo-
protein lipase (LPL) activity due to attenuated mobili-
zation of LPL from capillary endothelium may play an 
important role in the formation of echolucent plaques 
by modulation of postprandial lipids and subsequent 
fat accumulation in the arterial wall (42). Glycated he-
moglobin level was strongly related to the prevalence 
of carotid artery plaques with high echogenicity in 
nondiabetic individuals (43). Serum osteoprotegerin 
was inversely associated with carotid plaque echogeni-
city (44). Persons with carotid stenosis had significant-
ly higher plasma tissue-plasminogen activator antigen 
(t-PA ag) and vonWillebrand factor concentrations 
than controls, and there was a significant inverse 
relationship between t-PA ag and plaque echogenicity 
(P = 0.034) (45). Echogenic plaques were associated 
with higher levels of thrombin-antithrombin com-
plexes (TAT) and prothrombin fragment 1+2 (F1+2). 
TAT and F1+2 increased linearly with plaque echoge-
nicity, suggesting that increasing plaque echogenicity 
is associated with thrombin generation in persons with 
carotid stenosis (46). 
 
Predictors of plaque progression 
We evaluated predictors for plaque progression in 
1952 persons with pre-existing plaque at baseline (47). 
All plaque images were computer processed to yield a 
measure of plaque area and echogenicity, expressed as 
the GSM. After 7 years of follow-up, a new ultrasound 
screening was performed, and the changes in plaque 
area and echogenicity were assessed. In a multi-
variable adjusted model, age, systolic blood pressure, 
current smoking and HDL-cholesterol were indepen-
dent predictors of plaque growth (Table 4). For a 1-SD 
(0.41 mmol/L) lower HDL-cholesterol level, mean 
plaque area increased by 0.93 mm2, P = 0.03. When 
users of lipid-lowering drugs were excluded from 
analysis, the HDL estimate was strengthened (β = 1.46 
mm2, P = 0.002). Although plaque area increased in 
70% of cases, and most plaques became more echo-
genic over the follow-up interval, the plaques that 
became more echolucent grew more in size than those 
that became more echogenic (P = 0.002). This study 
showed that a high level of HDL-cholesterol is protec-
tive against plaque growth. Transformation of the 
plaque into higher echogenicity was associated with 
reduced growth. The findings of this study indicate 
that HDL-cholesterol stabilizes plaques and counteract 
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Figure 5.  Proportion of MI in men (A) and women (B) according to total plaque area. From 




their growth by reducing their lipid content and 
inflammation. Albuminuria was positively related to 
plaque-initiation and plaque-growth (48). The 
proinsulin-to-insulin ratio was found to be associated 
with progressive carotid artery plaque size in women, 
but not in men (49). 
 
Carotid plaque area as a predictor of first myocardial 
infarction 
In this prospective study, we measured carotid IMT, 
total plaque area, and plaque echogenicity as predic-
tors for first-ever MI (12). IMT, total plaque area, and 
plaque echogenicity were measured at baseline in 6226 
men and women aged 25 to 84 years with no previous 
MI. The subjects were followed for 6 years and inci-
dent MI was registered. During follow-up, MI occur-
red in 6.6% of men and 3.0% of women. The adjusted 
relative risk (RR; 95% CI) between the highest plaque 
area tertile versus no plaque was 1.56 (1.04–2.36) in 
men and 3.95 (2.16–7.19) in women (Figure 5). In 
women, there was a significant trend toward a higher 
MI risk with more echolucent plaque. The adjusted RR 
(95% CI) in the highest versus lowest IMT quartile 
was 1.73 (0.98–3.06) in men and 2.86 (1.07–7.65) in 
women. When we excluded bulb IMT from analyses, 
IMT did not predict MI in either sex. This study 
showed that in a general population, carotid plaque 
area is a stronger predictor of first-ever MI than is 
IMT. Moreover, carotid atherosclerosis seems to be a 
stronger risk factor for MI in women than in men. 
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Carotid stenosis and plaque echogenicity as predictors 
of ischemic cerebrovascular events and death 
The purpose of this study was to assess in a prospec-
tive design whether plaque morphology is associated 
with risk of ischemic stroke and other cerebrovascular 
events in subjects with carotid stenosis (19). A total of 
223 subjects were identified with carotid stenosis and 
matched with 215 control subjects by age and sex. 
Follow-up time was 3 years. Plaque echogenicity was 
assessed at baseline and scored as echolucent, pre-
dominantly echolucent, predominantly echogenic, or 
echogenic. Forty-four subjects experienced ≥1 
ischemic cerebrovascular events in the follow-up 
period. Plaque echogenicity, degree of stenosis, and 
white blood cell count were independent predictors of 
cerebrovascular events. The adjusted relative risk for 
cerebrovascular events in subjects with echolucent 
plaques was 4.6 (95% CI 1.1–18.9) compared to sub-
ject without stenosis, and there was a significant linear 
trend (P = 0.015) for higher risk with lower plaque 
echogenicity (Figure 6A). The adjusted relative risk 
for a 10% increase in the degree of stenosis was 1.2 
(95% CI 1.04–1.40). 
 In a 4-year follow-up study of 248 subjects with 
suspected carotid stenosis and 496 age- and sex-
matched controls, the number and causes of deaths 
were registered (50). The unadjusted relative risk for 
death was 2.72 (95% CI 1.57–4.75) for subjects with 
stenosis compared with control subjects. Adjusting for 
cardiovascular risk factors increased the relative risk to 
3.47 (95% CI 1.47–8.19) (Figure 6B). The adjusted 
relative risk in persons with stenosis and no cardio-
vascular disease or diabetes was 5.66 (95% CI 1.53–
20.90), which was higher than in subjects with stenosis 
and self-reported disease (1.79; 95% CI 0.75–4.27). 
There was a dose-response relationship between de-
gree of stenosis and risk of death (P = 0.002 for linear 
trend). Carotid stenosis was a stronger predictor of 
death than self-reported cardiovascular disease or 
diabetes. The major cause of death was MI. 
 At the moment, we are analysing the ischemic 
stroke endpoints in relation to IMT and plaque status 
at baseline. 
 
Carotid stenosis and cognitive function 
Performance on several neuropsychological tests was 
compared in 189 subjects with ultrasound-assessed ca-
rotid stenosis and 201 control subjects without carotid 
stenosis (51). Subjects with a previous history of 
stroke were excluded. The test battery included tests of 
attention, psychomotor speed, memory, language, 
speed of information processing, motor functioning, 
intelligence, and depression. Sagittal T1-weighted and 
axial and coronal T2-weighted spin echo MRI was 
performed, and presence of MRI lesions (white matter 
hyperintensities, lacunar and cortical infarcts) was 
recorded. Subjects with carotid stenosis had signifi-
cantly lower levels of performance in tests of attention, 
psychomotor speed, memory, and motor functioning,  
 
Figure 6. A) Graph of event-free survival for subjects with-
out stenosis and subjects with stenosis according to plaque 
echogenicity. A, Subjects without stenosis; B, subjects with 
echogenic and predominantly echogenic plaques; C, sub-
jects with predominantly echolucent plaques; and D, 
subjects with echolucent plaques. Probability values refer to 
comparison between group B, C, or D vs control subjects 
(A). From Mathiesen EB, et al. Circulation 2001; 103: 
2171-2175. Reprinted with permission. 
B) The 4.2-year survival curves for all subjects with (B) 
and without (A) carotid stenosis. From Joakimsen O, et al. 





independent of MRI lesions. There were no significant 
differences in tests of speed of information processing, 
word association, or depression. Cortical infarcts and 
white matter hyperintensities were equally distributed 
among persons with and without carotid stenosis. 
Lacunar infarcts were more frequent in the stenosis 
group (P = 0.03). Carotid stenosis was associated with 
poorer neuropsychological performance. This could 
not be explained by a higher proportion of silent MRI 
lesions in persons with asymptomatic carotid stenosis, 
making it less likely that the cognitive impairment was 
caused by silent emboli. 
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FUTURE POSSIBILITIES 
 
The sixth Tromsø survey started in September 2007 
and will be completed in December 2008. So far, more 
than 6000 persons have participated in the carotid 
ultrasound part of the study. The majority of these 
have participated at least once before. Thus, we will 
have unique long-term follow-up data of more than 13 
years on the natural history of initiation and progres-
sion of atherosclerosis in a large, population-based 
sample. The value of the measurements of athero-
sclerosis is of course dependent on information on risk 
factors and clinical end-point information obtained in 
the Tromsø Study. Of special interest is the association 
between atherosclerosis and cognitive function. Cogni-
tive tests were performed in the fifth survey in 2001 
and are currently being repeated in the sixth survey. 
This will enable us to study the association between 
atherosclerosis, cognitive function and cognitive de-
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